Science Explorer Back to mapMap
Discussion
Company · London · Canada

Viron Therapeutics (Canada)

vironinc.comROR OpenAlex
Research works
10
fractional, all time
Citations
254
25.5 per fractional work
Top-10% rate
9.4%
all institutions 10.0%
Open access
30%
world 40%
International
58%
world 18%
Viron Therapeutics (Canada)

Not ranked overall: Viron Therapeutics (Canada) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Viron Therapeutics (Canada) work in?

In all years, 51% of research at Viron Therapeutics (Canada) is in Health Sciences, 44% in Life Sciences. Its largest fields are Medicine (51%), Biochemistry, Genetics and Molecular Biology (25%), Immunology and Microbiology (12%). It does 1.6× the world's share of Life Sciences.

Health Sciences: 5 fractional works · 50.9% of its workMedicine: 5 fractional works · 50.9% of its workSurgery: 1 fractional works · 8.1% of its workOncology: 1 fractional works · 6.2% of its workHematology: 1 fractional works · 5.8% of its workEpidemiology: 1 fractional works · 5.4% of its workImmunology and Allergy: 0 fractional works · 4.6% of its workRehabilitation: 0 fractional works · 3.3% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 2.7% of its workPulmonary and Respiratory Medicine: 0 fractional works · 2.6% of its workInfectious Diseases: 0 fractional works · 2.2% of its workTransplantation: 0 fractional works · 2.2% of its workPsychiatry and Mental health: 0 fractional works · 2.0% of its workInternal Medicine: 0 fractional works · 1.7% of its workUrology: 0 fractional works · 1.7% of its workRheumatology: 0 fractional works · 1.5% of its workNephrology: 0 fractional works · 0.8% of its workLife Sciences: 4 fractional works · 44.1% of its workBiochemistry, Genetics and Molecular Biology: 2 fractional works · 24.8% of its workCancer Research: 1 fractional works · 9.3% of its workMolecular Biology: 1 fractional works · 5.6% of its workGenetics: 0 fractional works · 4.7% of its workBiochemistry: 0 fractional works · 3.3% of its workCell Biology: 0 fractional works · 1.8% of its workImmunology and Microbiology: 1 fractional works · 12.1% of its workImmunology: 1 fractional works · 9.3% of its workVirology: 0 fractional works · 1.7% of its workParasitology: 0 fractional works · 1.1% of its workAgricultural and Biological Sciences: 0 fractional works · 3.8% of its workPlant Science: 0 fractional works · 3.3% of its workAnimal Science and Zoology: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.1% of its workNeuroscience: 0 fractional works · 3.3% of its workCellular and Molecular Neuroscience: 0 fractional works · 1.7% of its workNeurology: 0 fractional works · 1.7% of its workPhysical Sciences: 0 fractional works · 5.0% of its workChemistry: 0 fractional works · 3.3% of its workOrganic Chemistry: 0 fractional works · 3.3% of its workEngineering: 0 fractional works · 1.7% of its workBiomedical Engineering: 0 fractional works · 1.7% of its workALL ITS WORKVironTherapeutics…10fractional works, all years
Life Sciences44%Physical Sciences5%Health Sciences51%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 7 fields, with their numbers
    1. Medicine550.9%
    1. Biochemistry, Genetics and Molecular Biology224.8%
    2. Immunology and Microbiology112.1%
    3. Agricultural and Biological Sciences03.8%
    4. Neuroscience03.3%
    1. Chemistry03.3%
    2. Engineering01.7%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 3.45× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 4.61× its world share, 0 worksBiochemistry, Geneti…Immunology and Microbiology: 10.86× its world share, 0 worksImmunology and Micro…Neuroscience: 10.10× its world share, 0 worksNeuroscienceChemistry: 10.45× its world share, 0 worksChemistryMedicine: 0.80× its world share, 0 worksMedicine1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 10.9×. Every wedge is a field page.

All 6 fields, with their numbers
  1. Immunology and Microbiology10.86×0 works
  2. Chemistry10.45×0 works
  3. Neuroscience10.10×0 works
  4. Biochemistry, Genetics and Molecular Biology4.61×0 works
  5. Agricultural and Biological Sciences3.45×0 works
  6. Medicine0.80×0 works

What are the most cited papers from Viron Therapeutics (Canada)?

The most cited paper from Viron Therapeutics (Canada) is "The Complete DNA Sequence of Myxoma Virus" (Cheryl Cameron, Sheela Hota‐Mitchell, Ling Chen et al., 1999), with 265 citations. Next come "A Randomized Controlled, Phase 2 Trial of the Viral Serpin Serp-1 in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention" (70) and "Complete Genomic Sequence and Comparative Analysis ofthe Tumorigenic Poxvirus Yaba Monkey TumorVirus" (55).

Most cited papers
#PaperReleasedCitations
1 The Complete DNA Sequence of Myxoma Virus Cheryl Cameron, Sheela Hota‐Mitchell, Ling Chen et al. · Virology Open access Nov 1999 265
2 A Randomized Controlled, Phase 2 Trial of the Viral Serpin Serp-1 in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention Jean‐Claude Tardif, Philippe L. L’Allier, Jean Grégoire et al. · Circulation Cardiovascular Interventions Open access 10 Nov 2010 70
3 Complete Genomic Sequence and Comparative Analysis ofthe Tumorigenic Poxvirus Yaba Monkey TumorVirus Craig R. Brunetti, Hiroko Amano, Yoshiaki Ueda et al. · Journal of Virology Open access 25 Nov 2003 55
4 Inhibition of Chemokine-Glycosaminoglycan Interactions in Donor Tissue Reduces Mouse Allograft Vasculopathy and Transplant Rejection Erbin Dai, Li-Ying Liu, Hao Wang et al. · PLoS ONE Open access 6 May 2010 53
5 VIRAL CHEMOKINE-BINDING PROTEINS INHIBIT INFLAMMATORY RESPONSES AND AORTIC ALLOGRAFT TRANSPLANT VASCULOPATHY IN RAT MODELS Liying Liu, Erbin Dai, Leslie W. Miller et al. · Transplantation Jun 2004 51
All 22 most cited papers, with filters and sorting

Which research topics does Viron Therapeutics (Canada) publish most on?

By volume in 2022-now: Free Radicals and Antioxidants, Pesticide Exposure and Toxicity, Biochemical Acid Research Studies and RNA regulation and disease.

Free Radicals and Antioxidants: 0 fractional worksPesticide Exposure and Toxicity: 0 fractional worksBiochemical Acid Researc…0Biochemical Acid Research Studies: 0 fractional worksRNA regulation and disease0RNA regulation and disease: 0 fractional worksHereditary Neurological …0Hereditary Neurological Disorders: 0 fractional worksNeurological diseases an…0Neurological diseases and metabolism: 0 fractional worksInfluenza Virus Research Studies: 0 fractional worksBipolar Disorder and Treatment: 0 fractional worksEpilepsy research and treatment: 0 fractional worksinterferon and immune responses: 0 fractional works
Organic ChemistryPlant ScienceBiochemistryMolecular Biology5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Free Radicals and Antioxidants Organic Chemistry 0 works
  2. 2 Pesticide Exposure and Toxicity Plant Science 0 works
  3. 3 Biochemical Acid Research Studies Biochemistry 0 works
  4. 4 RNA regulation and disease Molecular Biology 0 works
  5. 5 Hereditary Neurological Disorders Cellular and Molecular Neuroscience 0 works
  6. 6 Neurological diseases and metabolism Neurology 0 works
  7. 7 Influenza Virus Research Studies Epidemiology 0 works
  8. 8 Bipolar Disorder and Treatment Psychiatry and Mental health 0 works
  9. 9 Epilepsy research and treatment Psychiatry and Mental health 0 works
  10. 10 interferon and immune responses Immunology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available29.9%not open70.1%

World: 40% of research is openly available.

with international co-authors58.2%domestic only41.8%

World: 18% is written across borders.

How has Viron Therapeutics (Canada)'s research output changed?

still counting200020052010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Viron Therapeutics (Canada) as a percentage of every work published that year, 0.0000061% in 2023.

still counting0.000050%0.00010%Viron Therapeutics (Canada)0.000026% in 2025200020102020

Fractional works of Viron Therapeutics (Canada) over all fractional works that year. How the balance of science has shifted.

Other research institutions in London

All research institutions in London

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Viron Therapeutics (Canada). Posts are plain text and can be reported.